Literature DB >> 27411675

Cortisol and CBG - Getting cortisol to the right place at the right time.

David Henley1, Stafford Lightman2, Robin Carrell3.   

Abstract

Cortisol is transported in the blood by corticosteroid-binding globulin (CBG), a non-inhibitory member of the serpin family of serine protease inhibitors. Recent structural advances reveal how CBG acts as a releasing-agent as well as a carrier of cortisol. Taken together, the structures of the various forms of CBG and of the closely related thyroxine binding-globulin, show how the inherent conformational mechanism of the serpins has been adapted to modulate hormone release to the tissues by changes in binding affinities. A deduction from this, of the temperature dependence of hormone binding, is remarkably borne out with CBG, with a doubling in plasma free cortisol as the body temperature rises to 39°C. Another insight, against a dogma in the corticosteroid field, is that the proteolytic cleavage of CBG in inflammation results in a partial and not a complete loss of cortisol binding. This becomes of medical importance in conjunction with recent evidence of a pool of the circulating cleaved-form of CBG. It is now evident that tissue levels of free cortisol are buffered by two responsive plasma pools, intact CBG with a high binding-affinity and, particularly in inflammation and sepsis, a further pool of cleaved-CBG with a ten-fold lower affinity. The new molecular understandings, as well as providing insights into the differential release of circulating hormones, also open prospects for therapeutic interventions and draw attention to the potential of CBG and TBG as vehicles for the targeted delivery of drugs.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Body temperature; CBG; Cortisol; Inflammation; Serpin; TBG

Mesh:

Substances:

Year:  2016        PMID: 27411675     DOI: 10.1016/j.pharmthera.2016.06.020

Source DB:  PubMed          Journal:  Pharmacol Ther        ISSN: 0163-7258            Impact factor:   12.310


  13 in total

Review 1.  Adrenal insufficiency.

Authors:  Stefanie Hahner; Richard J Ross; Wiebke Arlt; Irina Bancos; Stephanie Burger-Stritt; David J Torpy; Eystein S Husebye; Marcus Quinkler
Journal:  Nat Rev Dis Primers       Date:  2021-03-11       Impact factor: 52.329

2.  Design of an allosterically modulated doxycycline and doxorubicin drug-binding protein.

Authors:  Karin Schmidt; Bernd R Gardill; Alina Kern; Peter Kirchweger; Michael Börsch; Yves A Muller
Journal:  Proc Natl Acad Sci U S A       Date:  2018-05-14       Impact factor: 11.205

3.  Genetic Variation and Mendelian Randomization Approaches.

Authors:  Mojgan Yazdanpanah; Nahid Yazdanpanah; Despoina Manousaki
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 3.650

4.  Pharmacokinetic Modeling of Hydrocortisone by Including Protein Binding to Corticosteroid-Binding Globulin.

Authors:  Eric Rozenveld; Nieko Punt; Martijn van Faassen; André P van Beek; Daan J Touw
Journal:  Pharmaceutics       Date:  2022-05-30       Impact factor: 6.525

5.  Pyrexia and acidosis act independently of neutrophil elastase reactive center loop cleavage to effect cortisol release from corticosteroid-binding globulin.

Authors:  Emily J Meyer; David J Torpy; Anastasia Chernykh; Morten Thaysen-Andersen; Marni A Nenke; John G Lewis; Harinda Rajapaksha; Wayne Rankin; Steven W Polyak
Journal:  Protein Sci       Date:  2020-11-04       Impact factor: 6.725

Review 6.  Adrenal function and dysfunction in critically ill patients.

Authors:  Arno Téblick; Bram Peeters; Lies Langouche; Greet Van den Berghe
Journal:  Nat Rev Endocrinol       Date:  2019-07       Impact factor: 43.330

7.  Granulocyte colony-stimulating factor blockade enables dexamethasone to inhibit lipopolysaccharide-induced murine lung neutrophils.

Authors:  Jesus Banuelos; Yun Cao; Soon Cheon Shin; Bruce S Bochner; Pedro Avila; Shihong Li; Xin Jiang; Mark W Lingen; Robert P Schleimer; Nick Z Lu
Journal:  PLoS One       Date:  2017-05-19       Impact factor: 3.240

Review 8.  Corticosteroids in septic shock: a systematic review and network meta-analysis.

Authors:  Ben Gibbison; José A López-López; Julian P T Higgins; Tom Miller; Gianni D Angelini; Stafford L Lightman; Djillali Annane
Journal:  Crit Care       Date:  2017-03-28       Impact factor: 9.097

9.  Opposite Expression of Hepatic and Pulmonary Corticosteroid-Binding Globulin in Cystic Fibrosis Patients.

Authors:  Anastasia Tchoukaev; Jessica Taytard; Nathalie Rousselet; Carine Rebeyrol; Dominique Debray; Sabine Blouquit-Laye; Marie-Pierre Moisan; Aline Foury; Loic Guillot; Harriet Corvol; Olivier Tabary; Philippe Le Rouzic
Journal:  Front Pharmacol       Date:  2018-06-05       Impact factor: 5.810

10.  The Synthesis and Structural Requirements for Measuring Glucocorticoid Receptor Expression In Vivo with (±)-11C-YJH08 PET.

Authors:  Yangjie Huang; Ning Zhao; Yung-Hua Wang; Charles Truillet; Junnian Wei; Matthew F L Parker; Joseph E Blecha; Christopher R Drake; Henry F VanBrocklin; Diego Garrido-Ruiz; Matthew P Jacobson; Rahul Aggarwal; Spencer C Behr; Robert R Flavell; David M Wilson; Youngho Seo; Michael J Evans
Journal:  J Nucl Med       Date:  2020-09-04       Impact factor: 10.057

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.